Immatics N.V. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
KROS
Keros Therapeutics, Inc. |
$13.71 | $556.78 M | -2.74 | 169 |
JANX
Janux Therapeutics, Inc. |
$25.65 | $1.52 B | -20.04 | 81 |
EWTX
Edgewise Therapeutics, Inc. |
$14.51 | $1.53 B | -10 | 110 |
KRON
Kronos Bio, Inc. |
$0.72 | $43.95 M | -0.5 | 10 |
LYEL
Lyell Immunopharma, Inc. |
$0.42 | $122.83 M | -0.32 | 300 |
MLYS
Mineralys Therapeutics, Inc. |
$14.76 | $957.57 M | -4.35 | 51 |
BCAB
BioAtla, Inc. |
$0.44 | $25.85 M | -0.31 | 61 |
INBX
Inhibrx Biosciences, Inc. |
$11.03 | $159.67 M | 0.1 | 156 |
ALXO
ALX Oncology Holdings Inc. |
$0.48 | $25.60 M | -0.19 | 80 |
AVTE
Aerovate Therapeutics, Inc. |
$2.68 | $77.68 M | -0.05 | 4 |
HRMY
Harmony Biosciences Holdings, Inc. |
$33.40 | $1.92 B | 12.75 | 268 |
FENC
Fennec Pharmaceuticals Inc. |
$6.12 | $168.88 M | -306 | 32 |
MRUS
Merus N.V. |
$39.44 | $2.73 B | -11.77 | 260 |
SNDX
Syndax Pharmaceuticals, Inc. |
$9.96 | $857.00 M | -2.59 | 270 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$31.39 | $2.94 B | -8.51 | 437 |
REPL
Replimune Group, Inc. |
$7.16 | $551.43 M | -2.33 | 331 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
